![](/img/cover-not-exists.png)
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Popat, S., Curioni-Fontecedro, A., Dafni, U., Shah, R., O'Brien, M., Pope, A., Fisher, P., Spicer, J., Roy, A., Gilligan, D., Gautschi, O., Nadal, E., Janthur, W.D., López Castro, R., GarcÃa CampeloJournal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.09.009
Date:
September, 2020
File:
PDF, 2.45 MB
2020